AEON Biopharma, Inc., headquartered in Newport Beach, California, is an innovative biopharmaceutical company focused on the development of advanced botulinum toxin products for various debilitating medical conditions. With a strong emphasis on proprietary formulations, AEON is well-positioned in the neuromodulators market, leveraging its robust pipeline to enhance treatment options and improve patient outcomes. The company is poised to capitalize on the increasing demand for effective therapeutic and aesthetic interventions, solidifying its role as a key player in the biopharmaceutical industry.
Click "Analyze" to generate stock analysis
AEON Price Trend and Signals
AEON Financials
2025-10-23Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-17Bearishprice_signal
Large price change detected: -21.43%.
2025-10-16Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-16Bullishprice_signal
Large price change detected: 27.27%.
2025-10-14Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-10Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-10Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-10Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.